SUBSCRIBERS
Tikehau Capital, Sprim join forces with new S'pore-based life sciences VC fund
Published Sun, Mar 11, 2018 · 09:50 PM
Singapore
LIFE science startups hoping for a big break can now look to a new Singapore-based cash cow for funding.
European asset manager Tikehau Capital and Sprim Ventures, the venture arm of global healthcare consultancy Sprim, have teamed up to launch a venture capital (VC) fund for early-stage investments.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Robinhood beats profit estimates on interest income strength
Prudential shutters Hong Kong wealth unit Pulse
Singapore has to be realistic on global trends plaguing its stock market: DPM Wong
Google DeepMind unveils next generation of drug discovery AI model
AEM Holdings Q1 net profit tumbles 85% to S$2.4 million
World’s biggest tea buyer Lipton’s sale of last farms is a strategy shift